{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T08:31:15Z","timestamp":1780561875382,"version":"3.54.1"},"reference-count":115,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"29","license":[{"start":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T00:00:00Z","timestamp":1721347200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,7,19]]},"abstract":"<jats:p>Opioids exert analgesic effects by agonizing opioid receptors and activating signaling pathways coupled to receptors such as G-protein and\/or \u03b2-arrestin. Concomitant respiratory depression (RD) is a common clinical problem, and improvement of RD is usually achieved with specific antagonists such as naloxone; however, naloxone antagonizes opioid analgesia and may produce more unknown adverse effects. In recent years, researchers have used various methods to isolate opioid receptor-mediated analgesia and RD, with the aim of preserving opioid analgesia while attenuating RD. At present, the focus is mainly on the development of new opioids with weak respiratory inhibition or the use of non-opioid drugs to stimulate breathing. This review reports recent advances in novel opioid agents, such as mixed opioid receptor agonists, peripheral selective opioid receptor agonists, opioid receptor splice variant agonists, biased opioid receptor agonists, and allosteric modulators of opioid receptors, as well as in non-opioid agents, such as AMPA receptor modulators, 5-hydroxytryptamine receptor agonists, phosphodiesterase-4 inhibitors, and nicotinic acetylcholine receptor agonists.<\/jats:p>","DOI":"10.1097\/md.0000000000038837","type":"journal-article","created":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T00:13:39Z","timestamp":1721434419000},"page":"e38837","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Advances in attenuating opioid-induced respiratory depression: A narrative review"],"prefix":"10.1097","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-4244-7970","authenticated-orcid":false,"given":"Yong-Zheng","family":"Fan","sequence":"first","affiliation":[{"name":"The 991st Hospital of Joint Logistic Support Force of People\u2019s Liberation Army, Xiangyang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Li","family":"Duan","sequence":"additional","affiliation":[{"name":"Xiangyang No. 4 Middle School Compulsory Education Department, Xiangyang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan-Tao","family":"Chen","sequence":"additional","affiliation":[{"name":"Taihe Country People\u2019s Hospital\u00b7The Taihe Hospital of Wannan Medical College, Fuyang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[{"name":"The 991st Hospital of Joint Logistic Support Force of People\u2019s Liberation Army, Xiangyang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An-Ping","family":"Zhu","sequence":"additional","affiliation":[{"name":"The 991st Hospital of Joint Logistic Support Force of People\u2019s Liberation Army, Xiangyang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250503","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.neuropharm.2019.02.008","article-title":"Respiratory depression and brain hypoxia induced by opioid drugs: morphine, oxycodone, heroin, and fentanyl.","volume":"151","author":"Kiyatkin","year":"2019","journal-title":"Neuropharmacology"},{"key":"R2-20250503","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1007\/s00204-021-03068-2","article-title":"Toxicities of opioid analgesics: Respiratory depression, histamine release, hemodynamic changes, hypersensitivity, serotonin toxicity.","volume":"95","author":"Baldo","year":"2021","journal-title":"Arch Toxicol"},{"key":"R3-20250503","doi-asserted-by":"crossref","first-page":"290","DOI":"10.15585\/mmwr.mm6911a4","article-title":"Drug and opioid-involved overdose deaths - United States, 2017-2018.","volume":"69","author":"Wilson","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R4-20250503","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1001\/jama.2020.18543","article-title":"The opioid epidemic during the COVID-19 Pandemic.","volume":"324","author":"Haley","year":"2020","journal-title":"JAMA"},{"key":"R5-20250503","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1213\/ANE.0000000000004788","article-title":"Prediction of opioid-induced Respiratory depression on inpatient wards using continuous capnography and oximetry: an international prospective, observational trial.","volume":"131","author":"Khanna","year":"2020","journal-title":"Anesth Analg"},{"key":"R6-20250503","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/cpt.2027","article-title":"Tolerance to Opioid-Induced Respiratory depression in chronic high-dose opioid users: a model-based comparison with opioid-na\u00efve individuals.","volume":"109","author":"Algera","year":"2021","journal-title":"Clin Pharmacol Ther"},{"key":"R7-20250503","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/ALN.0000000000004622","article-title":"Opioid overdose: limitations in naloxone reversal of Respiratory depression and prevention of cardiac arrest.","volume":"139","author":"van Lemmen","year":"2023","journal-title":"Anesthesiology"},{"key":"R8-20250503","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.cell.2022.12.026","article-title":"Structures of the entire human opioid receptor family.","volume":"186","author":"Wang","year":"2023","journal-title":"Cell"},{"key":"R9-20250503","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.3390\/molecules25184257","article-title":"Biased opioid ligands.","volume":"25","author":"Faouzi","year":"2020","journal-title":"Molecules"},{"key":"R10-20250503","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.neuron.2018.08.044","article-title":"Kappa opioid receptor distribution and function in primary afferents.","volume":"99","author":"Snyder","year":"2018","journal-title":"Neuron"},{"key":"R11-20250503","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.3389\/fphar.2018.01478","article-title":"Mu-opioid receptor agonist induces Kir3 Currents in mouse peripheral sensory neurons - Effects of Nerve Injury.","volume":"9","author":"St\u00f6tzner","year":"2018","journal-title":"Front Pharmacol"},{"key":"R12-20250503","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.nrl.2016.05.011","article-title":"Pre-B\u00f6tzinger complex: generation and modulation of respiratory rhythm.","volume":"34","author":"Mu\u00f1oz-Ortiz","year":"2019","journal-title":"Neurologia (Engl Ed)"},{"key":"R13-20250503","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1097\/ALN.0000000000000628","article-title":"Opioid-induced Respiratory depression Is Only Partially Mediated by the preB\u00f6tzinger complex in young and adult rabbits In Vivo.","volume":"122","author":"Stucke","year":"2015","journal-title":"Anesthesiology"},{"key":"R14-20250503","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1523\/JNEUROSCI.4611-10.2011","article-title":"PreBotzinger complex neurokinin-1 receptor-expressing neurons mediate opioid-induced Respiratory depression.","volume":"31","author":"Montandon","year":"2011","journal-title":"J Neurosci"},{"key":"R15-20250503","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/ALN.0000000000000984","article-title":"G-protein-gated inwardly rectifying potassium channels modulate Respiratory depression by Opioids.","volume":"124","author":"Montandon","year":"2016","journal-title":"Anesthesiology"},{"key":"R16-20250503","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1111\/bph.15760","article-title":"Strategies towards safer opioid analgesics-A review of old and upcoming targets.","volume":"180","author":"Varga","year":"2023","journal-title":"Br J Pharmacol"},{"key":"R17-20250503","doi-asserted-by":"crossref","first-page":"14122","DOI":"10.1038\/s41598-019-50613-2","article-title":"Electrocortical changes associating sedation and Respiratory depression by the opioid analgesic fentanyl.","volume":"9","author":"Montandon","year":"2019","journal-title":"Sci Rep"},{"key":"R18-20250503","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/s41598-020-57768-3","article-title":"The Role of peripheral opioid receptors in triggering heroin-induced brain hypoxia.","volume":"10","author":"Perekopskiy","year":"2020","journal-title":"Sci Rep"},{"key":"R19-20250503","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S1569-9048(03)00173-3","article-title":"Mu opioid receptors in rat ventral medulla: effects of endomorphin-1 on phrenic nerve activity.","volume":"138","author":"Lonergan","year":"2003","journal-title":"Respir Physiol Neurobiol"},{"key":"R20-20250503","doi-asserted-by":"crossref","first-page":"103482","DOI":"10.1016\/j.resp.2020.103482","article-title":"Activation of \u03bc-opioid receptors differentially affects the preB\u00f6tzinger Complex and neighbouring regions of the respiratory network in the adult rabbit.","volume":"280","author":"Cinelli","year":"2020","journal-title":"Respir Physiol Neurobiol"},{"key":"R21-20250503","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.resp.2016.10.004","article-title":"Mu-opioid receptors in the caudomedial NTS are critical for respiratory responses to stimulation of bronchopulmonary C-fibers and carotid body in conscious rats.","volume":"235","author":"Zhuang","year":"2017","journal-title":"Respir Physiol Neurobiol"},{"key":"R22-20250503","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.1113\/JP270822","article-title":"\u03bc opioid receptor activation hyperpolarizes respiratory-controlling K\u00f6lliker-Fuse neurons and suppresses post-inspiratory drive.","volume":"593","author":"Levitt","year":"2015","journal-title":"J Physiol"},{"key":"R23-20250503","doi-asserted-by":"crossref","first-page":"100078","DOI":"10.1016\/j.crtox.2022.100078","article-title":"Current research in pathophysiology of opioid-induced Respiratory depression, neonatal opioid withdrawal syndrome, and neonatal antidepressant exposure syndrome.","volume":"3","author":"Baldo","year":"2022","journal-title":"Curr Res Toxicol"},{"key":"R24-20250503","doi-asserted-by":"crossref","first-page":"e52694","DOI":"10.7554\/eLife.52694","article-title":"Opioids depress breathing through two small brainstem sites.","volume":"9","author":"Bachmutsky","year":"2020","journal-title":"Elife"},{"key":"R25-20250503","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/bph.15580","article-title":"Understanding and countering opioid-induced Respiratory depression.","volume":"180","author":"Bateman","year":"2023","journal-title":"Br J Pharmacol"},{"key":"R26-20250503","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/j.2040-4603.2020.tb00122.x","article-title":"Effects of perinatal hyperoxia on breathing.","volume":"10","author":"Bavis","year":"2020","journal-title":"Compr Physiol"},{"key":"R27-20250503","first-page":"1533","article-title":"Effects of naloxone on carotid body chemoreception and ventilation in the cat.","volume":"51","author":"Pokorski","year":"1981","journal-title":"J Appl Physiol Respir Environ Exerc Physiol"},{"key":"R28-20250503","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/ALN.0b013e3181c38c25","article-title":"Incidence, reversal, and prevention of opioid-induced Respiratory depression.","volume":"112","author":"Dahan","year":"2010","journal-title":"Anesthesiology"},{"key":"R29-20250503","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1124\/jpet.119.258566","article-title":"Noradrenergic mechanisms in fentanyl-mediated rapid death explain failure of naloxone in the opioid crisis.","volume":"371","author":"Torralva","year":"2019","journal-title":"J Pharmacol Exp Ther"},{"key":"R30-20250503","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1476-5381.1960.tb00277.x","article-title":"The anatomical basis of the straub phenomenon.","volume":"15","author":"Bilbey","year":"1960","journal-title":"Br J Pharmacol Chemother"},{"key":"R31-20250503","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0091-3057(87)90226-7","article-title":"Reversal of opioid-induced muscular rigidity in rats: evidence for alpha-2 adrenergic involvement.","volume":"28","author":"Jerussi","year":"1987","journal-title":"Pharmacol Biochem Behav"},{"key":"R32-20250503","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00000542-198908000-00013","article-title":"Dexmedetomidine, acting through central alpha-2 adrenoceptors, prevents opiate-induced muscle rigidity in the rat.","volume":"71","author":"Weinger","year":"1989","journal-title":"Anesthesiology"},{"key":"R33-20250503","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/0952-8180(94)90087-6","article-title":"Pretreatment with sedative-hypnotics, but not with nondepolarizing muscle relaxants, attenuates alfentanil-induced muscle rigidity.","volume":"6","author":"Sanford","year":"1994","journal-title":"J Clin Anesth"},{"key":"R34-20250503","doi-asserted-by":"crossref","first-page":"e1002396","DOI":"10.1371\/journal.pmed.1002396","article-title":"Gabapentin, opioids, and the risk of opioid-related death: a population-based nested case-control study.","volume":"14","author":"Gomes","year":"2017","journal-title":"PLoS Med"},{"key":"R35-20250503","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1111\/jcpt.13382","article-title":"The problem of postoperative Respiratory depression.","volume":"46","author":"Peppin","year":"2021","journal-title":"J Clin Pharm Ther"},{"key":"R36-20250503","doi-asserted-by":"crossref","first-page":"9623","DOI":"10.3390\/ijms23179623","article-title":"Bis-Cyclic guanidine heterocyclic peptidomimetics as opioid ligands with mixed \u03bc-, \u03ba- and \u03b4-Opioid receptor interactions: a potential approach to novel analgesics.","volume":"23","author":"McLaughlin","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R37-20250503","doi-asserted-by":"crossref","first-page":"7154","DOI":"10.1038\/s41598-022-11189-6","article-title":"Attenuated G protein signaling and minimal receptor phosphorylation as a biochemical signature of low side-effect opioid analgesics.","volume":"12","author":"Dasgupta","year":"2022","journal-title":"Sci Rep"},{"key":"R38-20250503","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s40122-021-00334-0","article-title":"Comparison of analgesic effects between Nalbuphine and Sufentanil in first-trimester surgical abortion: a randomized, double-blind, controlled trial.","volume":"11","author":"Fang","year":"2022","journal-title":"Pain Ther"},{"key":"R39-20250503","doi-asserted-by":"crossref","first-page":"14087","DOI":"10.1038\/s41598-018-32568-y","article-title":"Pharmacological characterization of dezocine, a Potent Analgesic Acting as a \u03ba partial agonist and \u03bc partial agonist.","volume":"8","author":"Wang","year":"2018","journal-title":"Sci Rep"},{"key":"R40-20250503","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/aps.2017.14","article-title":"The opioid receptor triple agonist DPI-125 produces analgesia with less RD and reduced abuse liability.","volume":"38","author":"Yi","year":"2017","journal-title":"Acta Pharmacol Sin"},{"key":"R41-20250503","doi-asserted-by":"crossref","first-page":"108445","DOI":"10.1016\/j.neuropharm.2020.108445","article-title":"The mixed kappa and delta opioid receptor agonist, MP1104, attenuates chemotherapy-induced neuropathic pain.","volume":"185","author":"Atigari","year":"2021","journal-title":"Neuropharmacology"},{"key":"R42-20250503","doi-asserted-by":"crossref","first-page":"e3483","DOI":"10.1126\/scitranslmed.aar3483","article-title":"A bifunctional nociceptin and mu opioid receptor agonist is analgesic without opioid side effects in nonhuman primates.","volume":"10","author":"Ding","year":"2018","journal-title":"Sci Transl Med"},{"key":"R43-20250503","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.2174\/1568026620666200508082615","article-title":"Nociceptin\/Orphanin FQ peptide receptor-related ligands as novel analgesics.","volume":"20","author":"Kiguchi","year":"2020","journal-title":"Curr Top Med Chem"},{"key":"R44-20250503","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/164_2019_211","article-title":"Effects of NOP-related ligands in nonhuman primates.","volume":"254","author":"Kiguchi","year":"2019","journal-title":"Handb Exp Pharmacol"},{"key":"R45-20250503","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1124\/jpet.114.213694","article-title":"Cebranopadol: a novel potent analgesic nociceptin\/orphanin FQ peptide and opioid receptor agonist.","volume":"349","author":"Linz","year":"2014","journal-title":"J Pharmacol Exp Ther"},{"key":"R46-20250503","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/164_2019_206","article-title":"Cebranopadol: a novel first-in-class potent analgesic acting via NOP and opioid receptors.","volume":"254","author":"Tzschentke","year":"2019","journal-title":"Handb Exp Pharmacol"},{"key":"R47-20250503","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/ALN.0000000000001529","article-title":"Respiratory effects of the Nociceptin\/Orphanin FQ peptide and opioid receptor agonist, cebranopadol, in healthy human volunteers.","volume":"126","author":"Dahan","year":"2017","journal-title":"Anesthesiology"},{"key":"R48-20250503","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1021\/acschemneuro.7b00195","article-title":"Novel opioid analgesics and side effects.","volume":"8","author":"Del Vecchio","year":"2017","journal-title":"ACS Chem Neurosci"},{"key":"R49-20250503","doi-asserted-by":"crossref","first-page":"4732","DOI":"10.1021\/acs.jcim.3c00197","article-title":"Fentanyl and the fluorinated fentanyl derivative NFEPP elicit distinct hydrogen-bond dynamics of the opioid receptor.","volume":"63","author":"Le\u0161nik","year":"2023","journal-title":"J Chem Inf Model"},{"key":"R50-20250503","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1136\/gutjnl-2021-324070","article-title":"Agonist that activates the \u00b5-opioid receptor in acidified microenvironments inhibits colitis pain without side effects.","volume":"71","author":"Jim\u00e9nez-Vargas","year":"2022","journal-title":"Gut"},{"key":"R51-20250503","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.tips.2017.08.004","article-title":"Designing safer analgesics via \u03bc-Opioid Receptor Pathways.","volume":"38","author":"Chan","year":"2017","journal-title":"Trends Pharmacol Sci"},{"key":"R52-20250503","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1126\/science.aai8636","article-title":"A nontoxic pain killer designed by modeling of pathological receptor conformations.","volume":"355","author":"Spahn","year":"2017","journal-title":"Science"},{"key":"R53-20250503","doi-asserted-by":"crossref","first-page":"8965","DOI":"10.1038\/s41598-018-27313-4","article-title":"Opioid receptor signaling, analgesic and side effects induced by a computationally designed pH-dependent agonist.","volume":"8","author":"Spahn","year":"2018","journal-title":"Sci Rep"},{"key":"R54-20250503","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/phar.1986","article-title":"Review of opioid pharmacogenetics and considerations for pain management.","volume":"37","author":"Owusu Obeng","year":"2017","journal-title":"Pharmacotherapy"},{"key":"R55-20250503","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1172\/JCI88760","article-title":"Alternatively spliced mu opioid receptor C termini impact the diverse actions of morphine.","volume":"127","author":"Xu","year":"2017","journal-title":"J Clin Invest"},{"key":"R56-20250503","doi-asserted-by":"crossref","first-page":"21211","DOI":"10.1074\/jbc.M113.458687","article-title":"Stabilization of the \u03bc-opioid receptor by truncated single transmembrane splice variants through a chaperone-like action.","volume":"288","author":"Xu","year":"2013","journal-title":"J Biol Chem"},{"key":"R57-20250503","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1200\/JCO.2013.53.1079","article-title":"Opiate pharmacology and relief of pain.","volume":"32","author":"Pasternak","year":"2014","journal-title":"J Clin Oncol"},{"key":"R58-20250503","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1172\/JCI81070","article-title":"Mediation of opioid analgesia by a truncated 6-transmembrane GPCR.","volume":"125","author":"Lu","year":"2015","journal-title":"J Clin Invest"},{"key":"R59-20250503","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s10571-020-00867-6","article-title":"Synthesis and Characterization of Azido Aryl Analogs of IBNtxA for Radio-Photoaffinity Labeling Opioid receptors in cell lines and in mouse brain.","volume":"41","author":"Grinnell","year":"2021","journal-title":"Cell Mol Neurobiol"},{"key":"R60-20250503","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1021\/acsptsci.0c00066","article-title":"Abuse Liability, anti-nociceptive, and discriminative stimulus properties of IBNtxA.","volume":"3","author":"Islam","year":"2020","journal-title":"ACS Pharmacol Transl Sci"},{"key":"R61-20250503","doi-asserted-by":"crossref","first-page":"19778","DOI":"10.1073\/pnas.1115231108","article-title":"Truncated G protein-coupled mu opioid receptor MOR-1 splice variants are targets for highly potent opioid analgesics lacking side effects.","volume":"108","author":"Majumdar","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"R62-20250503","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1124\/mol.107.040352","article-title":"Functional selectivity through protean and biased agonism: who steers the ship?","volume":"72","author":"Kenakin","year":"2007","journal-title":"Mol Pharmacol"},{"key":"R63-20250503","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.tips.2014.04.007","article-title":"Biased ligands at G-protein-coupled receptors: promise and progress.","volume":"35","author":"Violin","year":"2014","journal-title":"Trends Pharmacol Sci"},{"key":"R64-20250503","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nature14886","article-title":"Structural insights into \u00b5-opioid receptor activation.","volume":"524","author":"Huang","year":"2015","journal-title":"Nature"},{"key":"R65-20250503","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.cell.2017.10.035","article-title":"Bias factor and therapeutic window correlate to predict safer opioid analgesics.","volume":"171","author":"Schmid","year":"2017","journal-title":"Cell"},{"key":"R66-20250503","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/j.drudis.2017.07.002","article-title":"Mu-Opioid receptor biased ligands: a safer and painless discovery of analgesics?","volume":"22","author":"Madariaga-Maz\u00f3n","year":"2017","journal-title":"Drug Discov Today"},{"key":"R67-20250503","doi-asserted-by":"crossref","first-page":"8019","DOI":"10.1021\/jm4010829","article-title":"Structure-activity relationships and discovery of a G protein biased \u03bc opioid receptor ligand, [(3-methoxythiophen-2-yl)methyl]({2-[(9R)-9-(pyridin-2-yl)-6-oxaspiro-[4.5]decan-9-yl]ethyl})amine (TRV130), for the treatment of acute severe pain.","volume":"56","author":"Chen","year":"2013","journal-title":"J Med Chem"},{"key":"R68-20250503","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nature19112","article-title":"Structure-based discovery of opioid analgesics with reduced side effects.","volume":"537","author":"Manglik","year":"2016","journal-title":"Nature"},{"key":"R69-20250503","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1111\/bph.15409","article-title":"TRV130 partial agonism and capacity to induce anti-nociceptive tolerance revealed through reducing available \u03bc-opioid receptor number.","volume":"178","author":"Singleton","year":"2021","journal-title":"Br J Pharmacol"},{"key":"R70-20250503","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1124\/jpet.112.201616","article-title":"A G protein-biased ligand at the \u03bc-opioid receptor is potently analgesic with reduced gastrointestinal and respiratory dysfunction compared with morphine.","volume":"344","author":"DeWire","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"key":"R71-20250503","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/ALN.0000000000003441","article-title":"Benefit and risk evaluation of biased \u03bc-Receptor agonist oliceridine versus morphine.","volume":"133","author":"Dahan","year":"2020","journal-title":"Anesthesiology"},{"key":"R72-20250503","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1111\/bph.13823","article-title":"Allostery at opioid receptors: modulation with small molecule ligands.","volume":"175","author":"Livingston","year":"2018","journal-title":"Br J Pharmacol"},{"key":"R73-20250503","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1021\/acschemneuro.7b00090","article-title":"Recent advances in the realm of allosteric modulators for opioid receptors for future therapeutics.","volume":"8","author":"Remesic","year":"2017","journal-title":"ACS Chem Neurosci"},{"key":"R74-20250503","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1038\/s41386-018-0225-3","article-title":"Untangling the complexity of opioid receptor function.","volume":"43","author":"Valentino","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"R75-20250503","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/bph.12599","article-title":"Positive allosteric modulators of the \u03bc-opioid receptor: a novel approach for future pain medications.","volume":"172","author":"Burford","year":"2015","journal-title":"Br J Pharmacol"},{"key":"R76-20250503","doi-asserted-by":"crossref","first-page":"10830","DOI":"10.1073\/pnas.1300393110","article-title":"Discovery of positive allosteric modulators and silent allosteric modulators of the \u03bc-opioid receptor.","volume":"110","author":"Burford","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"R77-20250503","doi-asserted-by":"crossref","first-page":"e2000017118","DOI":"10.1073\/pnas.2000017118","article-title":"Positive allosteric modulation of the mu-opioid receptor produces analgesia with reduced side effects.","volume":"118","author":"Kandasamy","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"key":"R78-20250503","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/bph.12663","article-title":"Heteromers of \u03bc-\u03b4 opioid receptors: new pharmacology and novel therapeutic possibilities.","volume":"172","author":"Fujita","year":"2015","journal-title":"Br J Pharmacol"},{"key":"R79-20250503","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1124\/mol.111.072702","article-title":"Allosteric interactions between \u03b4 and \u03ba opioid receptors in peripheral sensory neurons.","volume":"81","author":"Berg","year":"2012","journal-title":"Mol Pharmacol"},{"key":"R80-20250503","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.neuropharm.2019.02.019","article-title":"Signaling characteristics and functional regulation of delta opioid-kappa opioid receptor (DOP-KOP) heteromers in peripheral sensory neurons.","volume":"151","author":"Jacobs","year":"2019","journal-title":"Neuropharmacology"},{"key":"R81-20250503","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0022-3565(25)10187-0","article-title":"The kappa opioid agonist U-50,488H antagonizes respiratory effects of mu opioid receptor agonists in conscious rats.","volume":"264","author":"Dosaka-Akita","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"R82-20250503","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.3389\/fphar.2018.01388","article-title":"Advances in achieving opioid analgesia without side effects.","volume":"9","author":"Machelska","year":"2018","journal-title":"Front Pharmacol"},{"key":"R83-20250503","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.neuropharm.2015.12.024","article-title":"Endomorphin analog analgesics with reduced abuse liability, Respiratory depression, motor impairment, tolerance, and glial activation relative to morphine.","volume":"105","author":"Zadina","year":"2016","journal-title":"Neuropharmacology"},{"key":"R84-20250503","doi-asserted-by":"crossref","first-page":"103401","DOI":"10.1016\/j.resp.2020.103401","article-title":"Endogenous glutamatergic inputs to the Parabrachial Nucleus\/K\u00f6lliker-Fuse Complex determine respiratory rate.","volume":"277","author":"Navarrete-Opazo","year":"2020","journal-title":"Respir Physiol Neurobiol"},{"key":"R85-20250503","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/jnc.15041","article-title":"Neurochemistry of the K\u00f6lliker-Fuse nucleus from a respiratory perspective.","volume":"156","author":"Varga","year":"2021","journal-title":"J Neurochem"},{"issue":"Pt A","key":"R86-20250503","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.neuropharm.2016.08.022","article-title":"Ca(2+)-permeable AMPA receptor: A new perspective on amyloid-beta mediated pathophysiology of Alzheimer\u2019s disease.","volume":"112","author":"Whitehead","year":"2017","journal-title":"Neuropharmacology"},{"key":"R87-20250503","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1097\/ALN.0b013e31819faa2a","article-title":"Ampakine CX717 protects against fentanyl-induced Respiratory depression and lethal apnea in rats.","volume":"110","author":"Ren","year":"2009","journal-title":"Anesthesiology"},{"key":"R88-20250503","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/clpt.2009.194","article-title":"Selective antagonism of opioid-induced ventilatory depression by an ampakine molecule in humans without loss of opioid analgesia.","volume":"87","author":"Oertel","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"R89-20250503","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbr.2017.07.020","article-title":"AMPAkines and morphine provide complementary analgesia.","volume":"334","author":"Sun","year":"2017","journal-title":"Behav Brain Res"},{"key":"R90-20250503","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ejphar.2015.05.067","article-title":"Tianeptine prevents Respiratory depression without affecting analgesic effect of opiates in conscious rats.","volume":"761","author":"Cavalla","year":"2015","journal-title":"Eur J Pharmacol"},{"key":"R91-20250503","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3389\/fphar.2019.00105","article-title":"The impact and mechanism of a novel allosteric AMPA Receptor Modulator LCX001 on Protection Against Respiratory depression in Rodents.","volume":"10","author":"Dai","year":"2019","journal-title":"Front Pharmacol"},{"key":"R92-20250503","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.resp.2008.05.014","article-title":"Contributions of 5-HT neurons to respiratory control: neuromodulatory and trophic effects.","volume":"164","author":"Hodges","year":"2008","journal-title":"Respir Physiol Neurobiol"},{"key":"R93-20250503","doi-asserted-by":"crossref","first-page":"R405","DOI":"10.1152\/ajpregu.00440.2005","article-title":"Zacopride and 8-OH-DPAT reverse opioid-induced Respiratory depression and hypoxia but not catatonic immobilization in goats.","volume":"290","author":"Meyer","year":"2006","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"R94-20250503","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1213\/ANE.0b013e3181eac011","article-title":"Repinotan, a selective 5-HT1A-R-agonist, antagonizes morphine-induced ventilatory depression in anesthetized rats.","volume":"111","author":"Guenther","year":"2010","journal-title":"Anesth Analg"},{"key":"R95-20250503","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/ALN.0b013e31823d08fa","article-title":"Selective 5-HT(1A)-R-agonist repinotan prevents remifentanil-induced ventilatory depression and prolongs antinociception.","volume":"116","author":"Guenther","year":"2012","journal-title":"Anesthesiology"},{"key":"R96-20250503","doi-asserted-by":"crossref","first-page":"4118","DOI":"10.1172\/JCI43029","article-title":"Serotonin receptor 1A-modulated phosphorylation of glycine receptor \u03b13 controls breathing in mice.","volume":"120","author":"Manzke","year":"2010","journal-title":"J Clin Invest"},{"key":"R97-20250503","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/sj.clpt.6100018","article-title":"The partial 5-hydroxytryptamine1A receptor agonist buspirone does not antagonize morphine-induced Respiratory depression in humans.","volume":"81","author":"Oertel","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"R98-20250503","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.clpt.2005.05.010","article-title":"The 5-hydroxytryptamine 4 receptor agonist mosapride does not antagonize morphine-induced Respiratory depression.","volume":"78","author":"L\u00f6tsch","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"R99-20250503","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.resp.2015.03.005","article-title":"Activation of 5-HT1A receptors in the preB\u00f6tzinger region has little impact on the respiratory pattern.","volume":"212-214","author":"Radocaj","year":"2015","journal-title":"Respir Physiol Neurobiol"},{"key":"R100-20250503","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1097\/ALN.0000000000002676","article-title":"Activating \u03b14\u03b22 Nicotinic Acetylcholine Receptors Alleviates Fentanyl-induced Respiratory depression in Rats.","volume":"130","author":"Ren","year":"2019","journal-title":"Anesthesiology"},{"key":"R101-20250503","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1097\/ALN.0000000000003128","article-title":"Countering Opioid-induced Respiratory depression in male rats with nicotinic acetylcholine receptor partial agonists varenicline and ABT 594.","volume":"132","author":"Ren","year":"2020","journal-title":"Anesthesiology"},{"key":"R102-20250503","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.resp.2014.06.002","article-title":"Methylxanthine reversal of opioid-induced Respiratory depression in the neonatal rat: mechanism and location of action.","volume":"200","author":"Mosca","year":"2014","journal-title":"Respir Physiol Neurobiol"},{"key":"R103-20250503","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.lfs.2015.02.006","article-title":"Blockade of phosphodiesterase 4 reverses morphine-induced ventilatory disturbance without loss of analgesia.","volume":"127","author":"Kimura","year":"2015","journal-title":"Life Sci"},{"key":"R104-20250503","doi-asserted-by":"crossref","first-page":"125","DOI":"10.5055\/jom.2017.0376","article-title":"Does caffeine improve respiratory rate during remifentanil target controlled infusion sedation? A case report in endoscopic sedation.","volume":"13","author":"Sbaraglia","year":"2017","journal-title":"J Opioid Manag"},{"key":"R105-20250503","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1152\/jn.00304.2018","article-title":"Doxapram stimulates respiratory activity through distinct activation of neurons in the nucleus hypoglossus and the pre-B\u00f6tzinger complex.","volume":"121","author":"Kruszynski","year":"2019","journal-title":"J Neurophysiol"},{"key":"R106-20250503","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1097\/ALN.0000000000000844","article-title":"Identification and characterization of GAL-021 as a novel breathing control modulator.","volume":"123","author":"Golder","year":"2015","journal-title":"Anesthesiology"},{"key":"R107-20250503","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/978-3-319-18440-1_41","article-title":"GAL-021 and GAL-160 are efficacious in rat models of obstructive and central sleep apnea and inhibit BKCa in isolated rat carotid body glomus cells.","volume":"860","author":"Dallas","year":"2015","journal-title":"Adv Exp Med Biol"},{"key":"R108-20250503","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1016\/j.bja.2018.12.023","article-title":"Opioid-induced Respiratory depression in humans: a review of pharmacokinetic-pharmacodynamic modelling of reversal.","volume":"122","author":"Algera","year":"2019","journal-title":"Br J Anaesth"},{"key":"R109-20250503","doi-asserted-by":"crossref","first-page":"R45","DOI":"10.1152\/ajpregu.00868.2004","article-title":"D1-dopamine receptor agonists prevent and reverse opiate depression of breathing but not antinociception in the cat.","volume":"289","author":"Lalley","year":"2005","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"R110-20250503","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1124\/jpet.118.248377","article-title":"Intravenous and intratracheal thyrotropin releasing hormone and its analog taltirelin reverse opioid-induced Respiratory depression in isoflurane anesthetized rats.","volume":"366","author":"Boghosian","year":"2018","journal-title":"J Pharmacol Exp Ther"},{"key":"R111-20250503","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.bja.2018.02.021","article-title":"Esketamine counters opioid-induced Respiratory depression.","volume":"120","author":"Jonkman","year":"2018","journal-title":"Br J Anaesth"},{"key":"R112-20250503","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.bbi.2008.07.008","article-title":"Minocycline suppresses morphine-induced Respiratory depression, suppresses morphine-induced reward, and enhances systemic morphine-induced analgesia.","volume":"22","author":"Hutchinson","year":"2008","journal-title":"Brain Behav Immun"},{"key":"R113-20250503","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejphar.2013.02.009","article-title":"Effects of cholinesterase inhibitors and serotonin-1A receptor agonists on morphine-induced ventilatory depression and antinociception in rats.","volume":"703","author":"Kimura","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"R114-20250503","doi-asserted-by":"crossref","first-page":"R1944","DOI":"10.1152\/ajpregu.2000.279.5.R1944","article-title":"Glycyl-glutamine inhibits the Respiratory depression, but not the antinociception, produced by morphine.","volume":"279","author":"Owen","year":"2000","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"R115-20250503","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.resp.2014.10.013","article-title":"Orexin-B antagonized Respiratory depression induced by sevoflurane, propofol, and remifentanil in isolated brainstem-spinal cords of neonatal rats.","volume":"205","author":"Umezawa","year":"2015","journal-title":"Respir Physiol Neurobiol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000038837","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:32:28Z","timestamp":1746318748000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000038837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,19]]},"references-count":115,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000038837","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,19]]}}}